pd 169316 has been researched along with Pemphigus in 1 studies
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor
Pemphigus: Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chernyavsky, AI | 1 |
| Arredondo, J | 1 |
| Kitajima, Y | 1 |
| Sato-Nagai, M | 1 |
| Grando, SA | 1 |
1 other study available for pd 169316 and Pemphigus
| Article | Year |
|---|---|
Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens.
Topics: Acantholysis; Antigens; Autoantibodies; Cell Adhesion; Cell Shape; Cells, Cultured; Cytoskeleton; De | 2007 |